| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 8e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.3 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |